Zweig Advisers’s Zimmer Biomet ZBH Stock Holding History

Zweig Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-103,000	Closed	-$10.9M	–	78
2015 Q2	$10.9M	Hold	103,000	–	–	1.66%	38
2015 Q1	$11.8M	Sell	103,000 -10,300	-9%	-$1.18M	1.69%	38
2014 Q4	$12.5M	Hold	113,300	–	–	1.71%	34
2014 Q3	$11.1M	Buy	113,300 +10,300	+10%	+$1.01M	1.6%	40
2014 Q2	$10.4M	Sell	103,000 -7,210	-7%	-$703K	1.45%	46
2014 Q1	$10.1M	Sell	110,210 -4,120	-4%	-$380K	1.43%	42
2013 Q4	$10.3M	Sell	114,330 -7,210	-6%	-$624K	1.42%	41
2013 Q3	$9.69M	Hold	121,540	–	–	1.44%	42
2013 Q2	$8.84M	Buy	+121,540	New	+$9.09M	1.36%	40

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Zweig Advisers's ZBH Position: Q3 2015 in Review

Zweig Advisers sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 103,000 shares — an estimated $10.9M sold.

Zweig Advisers first reported a position in ZBH in Q2 2013 and held it in 9 quarters. The position peaked at $12.5M in Q4 2014. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Zweig Advisers reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Zweig Advisers sold 103,000 Zimmer Biomet shares in Q3 2015, an estimated $10.9M.
Zweig Advisers first reported a position in Zimmer Biomet in Q2 2013 and held it in 9 quarters.
Zweig Advisers's Zimmer Biomet position peaked at $12.5M in Q4 2014.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Zweig Advisers's 13F filing for Q3 2015, filed 16 Nov 2015.